You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

150 Results
Drug
Jan 2018
Regimen
Cancer Type:
Gynecologic, 
Cervix
Intent: Curative
Jan 2018
Guidelines and Advice
Status: Current
ID: GL 8-11
Jan 2018
Regimen
Cancer Type:
Genitourinary, 
Testis
Intent: Curative
Jan 2018
Regimen
Cancer Type:
Genitourinary, 
Testis
Intent: Palliative
Jan 2018
Regimen
Cancer Type:
Breast, 
Central Nervous System, 
Endocrine, 
Gastrointestinal, 
Genitourinary, 
Gynecologic, 
Head and Neck, 
Hematologic, 
Lung, 
Sarcoma, 
Skin, 
Unknown Primary
Intent: Supportive Care, Palliative
Jan 2018
Regimen
Cancer Type:
Gynecologic, 
Vulva
Intent: Neoadjuvant, Adjuvant, Palliative
Jan 2018
Regimen
Cancer Type:
Gastrointestinal, 
Colorectal
Intent: Palliative
Sep 2021
Regimen
Cancer Type:
Hematologic, 
Leukemia - Acute Lymphoblastic (ALL)
Intent: Curative
Funding:
ODB - General Benefit
    mercaptopurine
ODB - General Benefit
    dexamethasone
New Drug Funding Program
    Pegaspargase (Outpatient) - Adult Acute Lymphoblastic Leukemia (ALL) Lymphoblastic Lymphoma Mixed or Biphenotypic Leukemia
Dec 2021
Regimen
Cancer Type:
Gynecologic, 
Ovary
Intent: Palliative
Jun 2021
Guidelines and Advice
Status: Current
Version: 2
May 2021

Pages